Financial Statement Restatements (Details) - USD ($)	Feb. 28, 2019	Feb. 28, 2018
Current assets
Cash and cash equivalents	$ 358,209	$ 748,008
Other current assets	59,849	42,165
Total current assets	418,058	790,173
Investment in joint venture	250,000	250,000
Total assets	668,058	1,040,173
Current liabilities
Accounts payable	2,635,664	5,377,259
Accrued expenses	3,205,456	3,211,635
Customer advances	1,136,542	503,632
Shares to be issued		2,280,964
Notes payable, current portion	847,537	777,537
Convertible notes payable and accrued interest-related party, net of discount	3,644,354	3,342,685
Convertible notes payable, net of discount		625,000
Notes payable and accrued interest-related party	6,156,375	5,353,980
Total current liabilities	17,625,929	21,472,692
Notes payable-related party	3,000,000	3,000,000
Note payable	215,181
Convertible notes payable	1,421,647	1,232,977
Total liabilities	22,262,757	25,705,669
Commitments and contingencies
Shareholders' deficit
Common stock, $0.0001 par value; 150,000,000 shares authorized at February 28, 2019 and 2018; 52,082,083 and 41,437,035 issued and outstanding at February 28, 2019 and 2018, respectively	5,371	4,144
Additional paid-in capital	442,519,092	438,247,091
Subscription receivable		(1,300,000)
Accumulated deficit	(464,119,161)	(461,616,731)
Previously Reported [Member]
Current assets
Cash and cash equivalents	358,209	748,008
Other current assets	59,849
Total current assets	418,058
Investment in joint venture	250,000
Total assets	668,058
Current liabilities
Accounts payable	2,704,269
Accrued expenses	3,383,369
Customer advances	1,136,542
Shares to be issued
Notes payable, current portion	777,537
Convertible notes payable and accrued interest-related party, net of discount	3,644,354
Convertible notes payable, net of discount	125,000
Notes payable and accrued interest-related party	6,156,375
Total current liabilities	17,927,446
Notes payable-related party	3,000,000
Note payable
Convertible notes payable	1,421,647
Total liabilities	22,349,093
Commitments and contingencies
Shareholders' deficit
Common stock, $0.0001 par value; 150,000,000 shares authorized at February 28, 2019 and 2018; 52,082,083 and 41,437,035 issued and outstanding at February 28, 2019 and 2018, respectively	5,209
Additional paid-in capital	444,386,887
Subscription receivable
Accumulated deficit	(466,073,131)
Total shareholders' deficit	(21,681,035)
Total liabilities and shareholders' deficit	668,058
Restatement Adjustment [Member]
Current assets
Cash and cash equivalents
Other current assets
Total current assets
Investment in joint venture
Total assets
Current liabilities
Accounts payable	(68,605)
Accrued expenses	(177,912)
Customer advances
Shares to be issued
Notes payable, current portion	70,000
Convertible notes payable and accrued interest-related party, net of discount
Convertible notes payable, net of discount	(125,000)
Notes payable and accrued interest-related party
Total current liabilities	(301,517)
Notes payable-related party
Note payable	215,181
Convertible notes payable
Total liabilities	(86,336)
Commitments and contingencies
Shareholders' deficit
Common stock, $0.0001 par value; 150,000,000 shares authorized at February 28, 2019 and 2018; 52,082,083 and 41,437,035 issued and outstanding at February 28, 2019 and 2018, respectively	162
Additional paid-in capital	(1,867,795)
Subscription receivable
Accumulated deficit	1,953,970
Total shareholders' deficit	86,336
Total liabilities and shareholders' deficit	0
Restated [Member]
Current assets
Cash and cash equivalents	358,209	$ 748,008
Other current assets	59,849
Total current assets	418,058
Investment in joint venture	250,000
Total assets	668,058
Current liabilities
Accounts payable	2,635,664
Accrued expenses	3,205,456
Customer advances	1,136,542
Shares to be issued
Notes payable, current portion	847,537
Convertible notes payable and accrued interest-related party, net of discount	3,644,354
Convertible notes payable, net of discount
Notes payable and accrued interest-related party	6,156,375
Total current liabilities	17,625,929
Notes payable-related party	3,000,000
Note payable	215,181
Convertible notes payable	1,421,647
Total liabilities	22,262,757
Commitments and contingencies
Shareholders' deficit
Common stock, $0.0001 par value; 150,000,000 shares authorized at February 28, 2019 and 2018; 52,082,083 and 41,437,035 issued and outstanding at February 28, 2019 and 2018, respectively	5,371
Additional paid-in capital	442,519,092
Subscription receivable
Accumulated deficit	(464,119,161)
Total shareholders' deficit	(21,594,699)
Total liabilities and shareholders' deficit	$ 668,058